CD8A and neoplasm: It is attractive to speculate that a reduction in pro-tumorigenic/immunosuppressive Tregs is counterbalanced by the reduction of other anti-tumorigenic CD4+ T cell subsets that support CD8+ T cell anti-tumor activity.